Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea

NCT03050086 PHASE1, PHASE2 COMPLETED

An open label feasibility study using BPX-04 topical minocycline gel in papulopustular rosacea.

Details

Lead sponsor	BioPharmX, Inc.
Phase	PHASE1, PHASE2
Status	COMPLETED
Enrolment	30
Start date	Wed Mar 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Moderate to Severe Papulopustular Rosacea

Interventions

• BPX-04 1% minocycline topical gel
• BPX-04 2% minocycline topical gel
• BPX-04 vehicle topical gel

Countries

United States